Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 21;12(1):86.
doi: 10.1186/s40249-023-01136-6.

Tackling barriers to scale up human papillomavirus vaccination in China: progress and the way forward

Xue-Lian Zhao #  1 , Shang-Ying Hu #  1 , Jia-Wei Hu  1 , Hong-Hao Wang  2 , Tian-Meng Wen  1 , Yu-Shu Feng  1 , You-Lin Qiao  2 , Fang-Hui Zhao  3 , Yong Zhang  4
Affiliations

Tackling barriers to scale up human papillomavirus vaccination in China: progress and the way forward

Xue-Lian Zhao et al. Infect Dis Poverty. .

Abstract

The human papillomavirus (HPV) vaccine is the first vaccine developed specifically targeting the prevention of cervical cancer. For more than 15 years, China has expedited a series of efforts on research and development of the domestically manufactured HPV vaccines, producing local population-based evidence, promoting free HPV vaccination from pilots, and launching action plans to tackle barriers in the scale-up of HPV vaccination. To further roll out the HPV vaccination program in China, several challenges should be addressed to support the steps forward. The availability of more locally manufactured HPV vaccines, pricing negotiation and local evidence supporting the efficacy of one-dose schedule would greatly alleviate the continued supply and financial constraints in China. Meanwhile, more attention should be paid to girls living in low-resource areas and males to ensure equal access to the HPV vaccination. Furthermore, linkage to secondary prevention and further real-world monitoring and evaluation are warranted to inform effective cervical cancer prevention strategies in the post-vaccine era.

Keywords: Challenge; China; Human papillomavirus; Progress; Vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests to disclose.

References

    1. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. 2020. https://gco.iarc.fr/today. Accessed 15 Apr 2023.
    1. World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. 2020. https://www.who.int/initiatives/cervical-cancer-elimination-initiative#cms. Accessed 15 Apr 2023.
    1. World Health Organization. HPV vaccine included in national immunization programme. 2023. https://app.powerbi.com/view?r=eyJrIjoiNDIxZTFkZGUtMDQ1Ny00MDZkLThiZDktY.... Accessed 15 July 2023.
    1. World Health Organization. Human papillomavirus (HPV) vaccination coverage. 2023. https://immunizationdata.who.int/pages/coverage/hpv.html?CODE=Global&ANT...=. Accessed 15 July 2023.
    1. National Medical Products Administrition. Registration and Information Disclosure Platform for Drug Clinical Studies. 2022. http://www.chinadrugtrials.org.cn/index.html. Accessed 16 Apr 2023.

Substances